Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

被引:0
作者
Paller, C. [1 ]
Zahurek, M. [1 ]
Mandl, A. [1 ]
Rudek, M. [1 ]
Heath, E. [2 ]
Marshall, C. H. [3 ]
Markowski, M. C. [3 ]
Lalji, A. [1 ]
Metri, N. [1 ]
Hoimes, C. J. [4 ]
Taksey, J. [5 ]
Durham, J. [6 ]
Kelly, W. [7 ]
Antonarakis, E. S. [8 ]
Eisenberger, M. [9 ]
Carducci, M. A. [10 ]
Denmeade, S. [1 ]
Levine, M. [11 ]
机构
[1] Johns Hopkins Univ Hosp, Oncol, Baltimore, MD USA
[2] Karmanos Canc Inst, Oncol, Detroit, MI USA
[3] Johns Hopkins Sidney Kimmel Canc Ctr, Oncol, Baltimore, MD USA
[4] Duke Canc Inst, Med Genitourinary Oncol, Durham, NC USA
[5] Columbia Clin, Oncol, Maryland Oncol Hematol, Columbia, MD USA
[6] Sidney Kimmel Comprehens Canc Ctr, Oncol, Johns Hopkins Med, Baltimore, MD USA
[7] Thomas Jefferson Univ, Oncol, Philadelphia, PA USA
[8] Univ Minnesota, Hematol Oncol & Transplantat, Mason Canc Ctr, Minneapolis, MD USA
[9] Johns Hopkins, Oncol Dept, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[10] Johns Hopkins Univ, Oncol Dept, Baltimore, MD USA
[11] NIDDK, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
关键词
D O I
10.1016/j.annonc.2023.09.2781
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1833P
引用
收藏
页码:S992 / S992
页数:1
相关论文
empty
未找到相关数据